Compare EOLS & DBCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EOLS | DBCA |
|---|---|---|
| Founded | 2012 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 500.0M | 432.3M |
| IPO Year | 2018 | 2025 |
| Metric | EOLS | DBCA |
|---|---|---|
| Price | $7.61 | $10.05 |
| Analyst Decision | Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 669.0K | 126.2K |
| Earning Date | 11-04-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.23 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $297,176,000.00 | N/A |
| Revenue This Year | $12.44 | N/A |
| Revenue Next Year | $17.37 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 11.61 | N/A |
| 52 Week Low | $3.86 | $9.83 |
| 52 Week High | $9.31 | $10.10 |
| Indicator | EOLS | DBCA |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 55.46 |
| Support Level | $7.59 | $9.98 |
| Resistance Level | $7.83 | $10.07 |
| Average True Range (ATR) | 0.32 | 0.01 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 79.57 | 60.00 |
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels. Its commercial products are: Jeuveau, a proprietary 900-kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe frown lines, in adults; and Evolysse, a collection of injectable HA gels that utilizes first-generation cold technology. The line includes several products, including mid face, nasolabial folds, lips, and eyes. Geographically, the company currently has operations in the United States, Canada, Europe, and Australia.
D Boral Acquisition I Corp is a blank check company. It is formed as a BVI business company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.